Variable

Response

H/M Ratio < 1.6 without SPECT Dyssynchrony (N = 5)

H/M Ratio < 1.6 with SPECT Dyssynchrony (N = 17)

Comparison

p-value

Male Gender

Yes

4 (80.0%)

11 (64.7%)

0.637 (F)

Black Race

Yes

5 (100.0%)

16 (94.1%)

1.000 (F)

Smoking Status

Never Smoked

1 (20.0%)

3 (17.6%)

0.728 (C-A)

Ex-Smoker

2 (40.0%)

10 (58.8%)

Current Smoker

2 (40.0%)

4 (23.5%)

DIABF

Yes

1 (20.0%)

6 (35.3%)

1.000 (F)

DYSLIP

Yes

5 (100.0%)

11 (64.7%)

0.266 (F)

HTN

Yes

5 (100.0%)

15 (88.2%)

1.000 (F)

CKD

Yes

3 (60.0%)

7 (41.2%)

0.624 (F)

AFIB

Yes

1 (20.0%)

3 (17.6%)

1.000 (F)

COPD

Yes

2 (40.0%)

4 (23.5%)

0.585 (F)

LBBB

Yes

0 (0.0%)

7 (41.2%)

0.135 (F)

RBBB

Yes

2 (40.0%)

0 (0.0%)

0.043 (F)^*

NYHA

II

3 (60.0%)

15 (88.2%)

0.210 (C-A)

III

2 (40.0%)

2 (11.8%)

NYHA Max

II

2 (40.0%)

6 (37.5%)

0.716 (C-A)

III

3 (60.0%)

8 (50.0%)

IV

0 (0.0%)

2 (12.5%)

Ischemic CHF

Yes

2 (40.0%)

4 (23.5%)

0.585 (F)

MI Hx

Yes

1 (20.0%)

5 (29.4%)

1.000 (F)

ICDENRF

Yes

1 (20.0%)

4 (23.5%)

1.000 (F)

AICD

Yes

2 (40.0%)

8 (47.1%)

1.000 (F)

BIV

Yes

0 (0.0%)

3 (17.6%)

1.000 (F)

ASA

Yes

4 (80.0%)

14 (82.4%)

1.000 (F)

Plavix

Yes

1 (20.0%)

1 (5.9%)

0.411 (F)

Ace-I

Yes

5 (100.0%)

11 (64.7%)

0.266 (F)

ARB

Yes

0 (0.0%)

6 (35.3%)

0.266 (F)

B-Blocker

Yes

5 (100.0%)

16 (94.1%)

1.000 (F)

Hydralazine Nitrate

Yes

1 (20.0%)

7 (41.2%)

0.613 (F)

Spironolactone

Yes

2 (40.0%)

9 (52.9%)

1.000 (F)

Digoxin

Yes

0 (0.0%)

4 (23.5%)

0.535 (F)

Statin

Yes

3 (60.0%)

12 (70.6%)

1.000 (F)